General Information of the Compound
Compound ID |
CP0382215
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(2,4-dibromo-1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-methylpyrazine-2-carboxamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C17H19Br2N7O3
|
||||||||||||||||||
Molecular Weight |
529.193
|
||||||||||||||||||
Canonical SMILES |
Cc1cnc(cn1)C(=O)N[C@@H](Cc1nc(Br)[nH]c1Br)C(=O)N1CCC[C@H]1C(N)=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C17H19Br2N7O3/c1-8-6-22-11(7-21-8)15(28)23-10(5-9-13(18)25-17(19)24-9)16(29)26-4-2-3-12(26)14(20)27/h6-7,10,12H,2-5H2,1H3,(H2,20,27)(H,23,28)(H,24,25)/t10-,12-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
ZWYVFBBBUUPCJC-JQWIXIFHSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04668, Thyrotropin-releasing hormone receptor
Protein ID: PT00626, Thyrotropin-releasing hormone receptor